Elizabeth J. Faul, Ph.D.
Affiliations: | 2010 | Immunology and Microbial Pathogenesis | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Microbiology Biology, Virology BiologyGoogle:
"Elizabeth Faul"Parents
Sign in to add mentorMatthias J. Schnell | grad student | 2010 | Thomas Jefferson | |
(A comprehensive analysis of interferon-beta's role in shaping the immunogenicity and pathogenicity of rabies virus: Development of a novel vaccine vector.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wanjalla CN, Faul EJ, Gomme EA, et al. (2010) Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 29: 130-40 |
Faul EJ, Wanjalla CN, Suthar MS, et al. (2010) Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. Plos Pathogens. 6: e1001016 |
Gomme EA, Faul EJ, Flomenberg P, et al. (2010) Characterization of a single-cycle rabies virus-based vaccine vector. Journal of Virology. 84: 2820-31 |
Faul EJ, Lyles DS, Schnell MJ. (2009) Interferon response and viral evasion by members of the family rhabdoviridae. Viruses. 1: 832-51 |
Faul EJ, Aye PP, Papaneri AB, et al. (2009) Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge. Vaccine. 28: 299-308 |
Snook AE, Li P, Stafford BJ, et al. (2009) Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Research. 69: 3537-44 |
Faul EJ, Lyles DS, Schnell MJ. (2009) Interferon response and viral evasion by members of the family rhabdoviridae Viruses. 1: 832-851 |
Faul EJ, Wanjalla CN, McGettigan JP, et al. (2008) Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology. 382: 226-38 |